853 related articles for article (PubMed ID: 26403950)
1. The importance of the Non Obese Diabetic (NOD) mouse model in autoimmune diabetes.
Pearson JA; Wong FS; Wen L
J Autoimmun; 2016 Jan; 66():76-88. PubMed ID: 26403950
[TBL] [Abstract][Full Text] [Related]
2. Bridging Mice to Men: Using HLA Transgenic Mice to Enhance the Future Prediction and Prevention of Autoimmune Type 1 Diabetes in Humans.
Serreze DV; Niens M; Kulik J; DiLorenzo TP
Methods Mol Biol; 2016; 1438():137-51. PubMed ID: 27150089
[TBL] [Abstract][Full Text] [Related]
3. TRIF deficiency protects non-obese diabetic mice from type 1 diabetes by modulating the gut microbiota and dendritic cells.
Gülden E; Chao C; Tai N; Pearson JA; Peng J; Majewska-Szczepanik M; Zhou Z; Wong FS; Wen L
J Autoimmun; 2018 Sep; 93():57-65. PubMed ID: 29960834
[TBL] [Abstract][Full Text] [Related]
4. The role of the innate immune system in destruction of pancreatic beta cells in NOD mice and humans with type I diabetes.
Tai N; Wong FS; Wen L
J Autoimmun; 2016 Jul; 71():26-34. PubMed ID: 27021275
[TBL] [Abstract][Full Text] [Related]
5. Norovirus Changes Susceptibility to Type 1 Diabetes by Altering Intestinal Microbiota and Immune Cell Functions.
Pearson JA; Tai N; Ekanayake-Alper DK; Peng J; Hu Y; Hager K; Compton S; Wong FS; Smith PC; Wen L
Front Immunol; 2019; 10():2654. PubMed ID: 31798584
[TBL] [Abstract][Full Text] [Related]
6. Role of innate immunity in triggering and tuning of autoimmune diabetes.
Kim HS; Lee MS
Curr Mol Med; 2009 Feb; 9(1):30-44. PubMed ID: 19199940
[TBL] [Abstract][Full Text] [Related]
7. Selective destruction of mouse islet beta cells by human T lymphocytes in a newly-established humanized type 1 diabetic model.
Zhao Y; Guo C; Hwang D; Lin B; Dingeldein M; Mihailescu D; Sam S; Sidhwani S; Zhang Y; Jain S; Skidgel RA; Prabhakar BS; Mazzone T; Holterman MJ
Biochem Biophys Res Commun; 2010 Sep; 399(4):629-36. PubMed ID: 20691153
[TBL] [Abstract][Full Text] [Related]
8. Modulation of Gut Microbiota by Low Methoxyl Pectin Attenuates Type 1 Diabetes in Non-obese Diabetic Mice.
Wu C; Pan LL; Niu W; Fang X; Liang W; Li J; Li H; Pan X; Chen W; Zhang H; Lakey JRT; Agerberth B; de Vos P; Sun J
Front Immunol; 2019; 10():1733. PubMed ID: 31417546
[TBL] [Abstract][Full Text] [Related]
9. IL-2 immunotherapy reveals potential for innate beta cell regeneration in the non-obese diabetic mouse model of autoimmune diabetes.
Diaz-de-Durana Y; Lau J; Knee D; Filippi C; Londei M; McNamara P; Nasoff M; DiDonato M; Glynne R; Herman AE
PLoS One; 2013; 8(10):e78483. PubMed ID: 24205242
[TBL] [Abstract][Full Text] [Related]
10. "Humanized" HLA transgenic NOD mice to identify pancreatic beta cell autoantigens of potential clinical relevance to type 1 diabetes.
Serreze DV; Marron MP; Dilorenzo TP
Ann N Y Acad Sci; 2007 Apr; 1103():103-11. PubMed ID: 17376821
[TBL] [Abstract][Full Text] [Related]
11. Gut Microbiota-Stimulated Innate Lymphoid Cells Support β-Defensin 14 Expression in Pancreatic Endocrine Cells, Preventing Autoimmune Diabetes.
Miani M; Le Naour J; Waeckel-Enée E; Verma SC; Straube M; Emond P; Ryffel B; van Endert P; Sokol H; Diana J
Cell Metab; 2018 Oct; 28(4):557-572.e6. PubMed ID: 30017352
[TBL] [Abstract][Full Text] [Related]
12. Advances in our understanding of the pathophysiology of Type 1 diabetes: lessons from the NOD mouse.
Jayasimhan A; Mansour KP; Slattery RM
Clin Sci (Lond); 2014 Jan; 126(1):1-18. PubMed ID: 24020444
[TBL] [Abstract][Full Text] [Related]
13. Gut microbiota from B-cell-specific TLR9-deficient NOD mice promote IL-10
Yang X; Huang J; Peng J; Wang P; Wong FS; Wang R; Wang D; Wen L
Front Immunol; 2024; 15():1413177. PubMed ID: 38903498
[TBL] [Abstract][Full Text] [Related]
14. IL-10 Deficiency Accelerates Type 1 Diabetes Development
Huang J; Tan Q; Tai N; Pearson JA; Li Y; Chao C; Zhang L; Peng J; Xing Y; Zhang L; Hu Y; Zhou Z; Wong FS; Wen L
Front Immunol; 2021; 12():702955. PubMed ID: 34394099
[TBL] [Abstract][Full Text] [Related]
15. Artesunate prevents type 1 diabetes in NOD mice mainly by inducing protective IL-4-producing T cells and regulatory T cells.
Li Z; Shi X; Liu J; Shao F; Huang G; Zhou Z; Zheng P
FASEB J; 2019 Jul; 33(7):8241-8248. PubMed ID: 30916998
[TBL] [Abstract][Full Text] [Related]
16. Autoimmune Diabetes: An Overview of Experimental Models and Novel Therapeutics.
You S; Chatenoud L
Methods Mol Biol; 2016; 1371():117-42. PubMed ID: 26530798
[TBL] [Abstract][Full Text] [Related]
17. Nucleotide-binding oligomerization domain-containing protein 2 (Nod2) modulates T1DM susceptibility by gut microbiota.
Li YY; Pearson JA; Chao C; Peng J; Zhang X; Zhou Z; Liu Y; Wong FS; Wen L
J Autoimmun; 2017 Aug; 82():85-95. PubMed ID: 28592385
[TBL] [Abstract][Full Text] [Related]
18. Transient Depletion of Foxp3
Watts D; Janßen M; Jaykar M; Palmucci F; Weigelt M; Petzold C; Hommel A; Sparwasser T; Bonifacio E; Kretschmer K
Front Immunol; 2021; 12():720133. PubMed ID: 34447385
[TBL] [Abstract][Full Text] [Related]
19. Host gene effects on gut microbiota in type 1 diabetes.
Guo K; Huang J; Zhou Z
Biochem Soc Trans; 2022 Jun; 50(3):1133-1142. PubMed ID: 35521897
[TBL] [Abstract][Full Text] [Related]
20. The role of Toll-like receptor pathways in the mechanism of type 1 diabetes.
Lien E; Zipris D
Curr Mol Med; 2009 Feb; 9(1):52-68. PubMed ID: 19199942
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
